AP78A - Therapeutic nucleosides - Google Patents

Therapeutic nucleosides Download PDF

Info

Publication number
AP78A
AP78A APAP/P/1988/000086A AP8800086A AP78A AP 78 A AP78 A AP 78A AP 8800086 A AP8800086 A AP 8800086A AP 78 A AP78 A AP 78A
Authority
AP
ARIPO
Prior art keywords
substituted
formula
compound
dideoxyribofuranoside
group
Prior art date
Application number
APAP/P/1988/000086A
Other languages
English (en)
Other versions
AP8800086A0 (en
Inventor
George Walter Koszalka
Thomas Anthony Krenitsky
Janet Litster Rideout
Charlene Louise Burns
Original Assignee
The Wellcome Foundation Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB878708512A external-priority patent/GB8708512D0/en
Priority claimed from GB878712691A external-priority patent/GB8712691D0/en
Priority claimed from GB878723013A external-priority patent/GB8723013D0/en
Publication of AP8800086A0 publication Critical patent/AP8800086A0/xx
Application filed by The Wellcome Foundation Ltd filed Critical The Wellcome Foundation Ltd
Application granted granted Critical
Publication of AP78A publication Critical patent/AP78A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/16—Purine radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D473/00—Heterocyclic compounds containing purine ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Virology (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • AIDS & HIV (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
APAP/P/1988/000086A 1987-04-09 1988-04-08 Therapeutic nucleosides AP78A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB878708512A GB8708512D0 (en) 1987-04-09 1987-04-09 Therapeutic nucleosides
GB878712691A GB8712691D0 (en) 1987-05-29 1987-05-29 Therapeutic nucleosides
GB878723013A GB8723013D0 (en) 1987-09-30 1987-09-30 Therapeutic nucleosides

Publications (2)

Publication Number Publication Date
AP8800086A0 AP8800086A0 (en) 1988-02-01
AP78A true AP78A (en) 1990-03-12

Family

ID=27263377

Family Applications (1)

Application Number Title Priority Date Filing Date
APAP/P/1988/000086A AP78A (en) 1987-04-09 1988-04-08 Therapeutic nucleosides

Country Status (20)

Country Link
US (1) US5068320A (fr)
EP (1) EP0286425B1 (fr)
JP (1) JP2763888B2 (fr)
KR (1) KR880012630A (fr)
AP (1) AP78A (fr)
AT (1) ATE116984T1 (fr)
AU (1) AU608590B2 (fr)
CA (1) CA1326237C (fr)
CS (1) CS274461B2 (fr)
DE (1) DE3852710T2 (fr)
DK (1) DK191688A (fr)
FI (1) FI87214C (fr)
HU (1) HU201954B (fr)
IL (1) IL86007A0 (fr)
MC (1) MC1915A1 (fr)
NO (1) NO171641C (fr)
NZ (1) NZ224189A (fr)
PL (1) PL154956B1 (fr)
PT (1) PT87191B (fr)
RU (1) RU1779256C (fr)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5185437A (en) * 1987-04-09 1993-02-09 Burroughs Wellcome Co. Therapeutic nucleosides
IL86007A0 (en) * 1987-04-09 1988-09-30 Wellcome Found 6-substituted purine nucleosides,their preparation and pharmaceutical compositions containing them
US5077280A (en) * 1988-04-12 1991-12-31 Brown University Research Foundation Treatment of viral infections
IE882585L (en) * 1988-08-25 1990-02-25 Prendergast Patrick T Viral treatment system
DE68907013D1 (de) * 1988-10-24 1993-07-15 Wellcome Found Guaninderivate mit antiviraler wirkung und deren pharmazeutisch vertraegliche salze.
AU4817490A (en) * 1988-11-29 1990-06-26 Institut Fur Molekularbiologie Und Analytik (Ima) G.M.B.H. 2',3'-dideoxyribofuranosides and process for producing them
JP2619710B2 (ja) * 1989-02-27 1997-06-11 日本製紙 株式会社 ２′，３′−ジデオキシプリンヌクレオシド類の製造方法
US5585364A (en) * 1989-04-13 1996-12-17 British Technology Group Limited Antiviral compounds
US5013829A (en) * 1989-04-26 1991-05-07 University Of Iowa Research Foundation Stable congener of 2',3'-dideoxyadenosine
DE4020529A1 (de) * 1989-09-12 1991-03-21 Roxana Vasiloiu Multifunktionelle(s) enzym(e) mit nucleosid-didesoxyribosyltransferase(n) und/oder nucleoside-desoxyribosyltransferasen(n) und/oder kinease- und/oder reduktase- und/oder desaminase- und/oder polymerase-aktivitaet
JPH0637391B2 (ja) * 1989-09-29 1994-05-18 日本製紙株式会社 抗エイズウイルス剤
PT95516A (pt) * 1989-10-06 1991-08-14 Wellcome Found Processo para a preparacao de derivados de 2',3'-didesoxi nucleosidos 6-substituidos
EP0544668A1 (fr) * 1990-02-09 1993-06-09 THE UNITED STATES OF AMERICA as represented by the Secretary UNITED STATES DEPARTMENT OF COMMERCE -6-fluoro-9-(2,3-didesoxy-b-d-glycero-pentofuranosyl)-9h-purines ainsi que leur emploi en tant qu'agents antiviraux
US5654286A (en) * 1993-05-12 1997-08-05 Hostetler; Karl Y. Nucleotides for topical treatment of psoriasis, and methods for using same
ID30477A (id) * 1998-12-23 2001-12-13 Shire Biochem Inc Analog nukleosida antivirus
CN101220071B (zh) * 2008-01-17 2011-04-06 南京长澳医药科技有限公司 稳定的6-甲氧基-2’,3’-双脱氧鸟嘌呤核苷及其制备方法和包含它的药物组合物
CN102234280B (zh) * 2010-04-26 2014-01-08 北京大学 D,l-鸟嘌呤核苷类似物及其制备方法和应用
BR112013005872A2 (pt) 2010-09-22 2019-09-24 Alios Biopharma Inc compostos, composição farmacêutica e respectivos usos
CA2837207A1 (fr) 2011-06-01 2012-12-06 Janus Biotherapeutics, Inc. Nouveaux modulateurs du systeme immunitaire
WO2013096680A1 (fr) 2011-12-22 2013-06-27 Alios Biopharma, Inc. Analogues de nucléotide phosphorothioate substitués
NZ631601A (en) 2012-03-21 2016-06-24 Alios Biopharma Inc Solid forms of a thiophosphoramidate nucleotide prodrug
US9012427B2 (en) 2012-03-22 2015-04-21 Alios Biopharma, Inc. Pharmaceutical combinations comprising a thionucleotide analog
BR112015021677A2 (pt) * 2013-03-05 2017-07-18 Hoffmann La Roche inibidores de tirosina quinase de bruton

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0216511A2 (fr) * 1985-08-26 1987-04-01 THE UNITED STATES OF AMERICA as represented by the Secretary United States Department of Commerce Inhibition de l'infectivité in vitro et de l'effet cytopathique du HTLV-III/LAV par la 2'3'-didéoxycytidine
EP0246497A2 (fr) * 1986-05-20 1987-11-25 The Firestone Tire & Rubber Company Procédé de fabrication d'une carcasse de pneu radial pour véhicules

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1573777A (en) * 1977-11-03 1980-08-28 Wellcome Found 9-d-arabinonucleosides and an enzymatic process for their preparation
US4724232A (en) * 1985-03-16 1988-02-09 Burroughs Wellcome Co. Treatment of human viral infections
ATE44464T1 (de) * 1985-03-16 1989-07-15 Wellcome Found Antivirale nukleoside.
CA1314875C (fr) * 1985-05-15 1993-03-23 George Walter Koszalka Nucleosides therapeutiques
EP0217580A3 (fr) * 1985-09-17 1990-11-07 The Wellcome Foundation Limited Nucléosides thérapeutiques
EP0342203B1 (fr) * 1987-03-24 1994-07-06 Nycomed Imaging As Derives d'oxyde de 2',3' didesoxyribofuranne
IL86007A0 (en) * 1987-04-09 1988-09-30 Wellcome Found 6-substituted purine nucleosides,their preparation and pharmaceutical compositions containing them
NZ225447A (en) * 1987-07-20 1991-12-23 Merck & Co Inc Piperazinyl derivatives of purine and purine isosteres and pharmaceutical compositions

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0216511A2 (fr) * 1985-08-26 1987-04-01 THE UNITED STATES OF AMERICA as represented by the Secretary United States Department of Commerce Inhibition de l'infectivité in vitro et de l'effet cytopathique du HTLV-III/LAV par la 2'3'-didéoxycytidine
EP0246497A2 (fr) * 1986-05-20 1987-11-25 The Firestone Tire & Rubber Company Procédé de fabrication d'une carcasse de pneu radial pour véhicules

Also Published As

Publication number Publication date
NO881537D0 (no) 1988-04-08
PT87191A (pt) 1988-05-01
DE3852710T2 (de) 1995-05-24
FI87214C (fi) 1992-12-10
EP0286425B1 (fr) 1995-01-11
IL86007A0 (en) 1988-09-30
PT87191B (pt) 1993-02-26
AU1444488A (en) 1988-10-13
NO171641C (no) 1993-04-14
NO171641B (no) 1993-01-04
FI881651A0 (fi) 1988-04-08
PL154956B1 (en) 1991-10-31
KR880012630A (ko) 1988-11-28
HUT48269A (en) 1989-05-29
EP0286425A2 (fr) 1988-10-12
JP2763888B2 (ja) 1998-06-11
CS242188A2 (en) 1990-09-12
NO881537L (no) 1988-10-10
US5068320A (en) 1991-11-26
DE3852710D1 (de) 1995-02-23
FI87214B (fi) 1992-08-31
AU608590B2 (en) 1991-04-11
DK191688A (da) 1988-10-10
JPS63267796A (ja) 1988-11-04
AP8800086A0 (en) 1988-02-01
ATE116984T1 (de) 1995-01-15
DK191688D0 (da) 1988-04-08
HU201954B (en) 1991-01-28
PL271722A1 (en) 1989-01-23
CA1326237C (fr) 1994-01-18
CS274461B2 (en) 1991-04-11
MC1915A1 (fr) 1989-04-06
NZ224189A (en) 1991-09-25
FI881651A (fi) 1988-10-10
RU1779256C (ru) 1992-11-30
EP0286425A3 (en) 1990-12-05

Similar Documents

Publication Publication Date Title
AP78A (en) Therapeutic nucleosides
EP0206497B1 (fr) Nucléosides thérapeutiques et leur préparation
DK167377B1 (da) 3'-azidopyrimidinnucleosider eller farmaceutisk acceptable salte eller estere deraf til anvendelse ved behandling af eller profylakse for en human retrovirusinfektion
US5185437A (en) Therapeutic nucleosides
EP0199451A2 (fr) Nucléosides thérapeutiques
EP0285432B1 (fr) Nucléosides thérapeutiques
US5071983A (en) Therapeutic nucleosides
AU637831B2 (en) Therapeutic necleosides
AU616914B2 (en) Therapeutic necleosides
US4920210A (en) 2,6-diaminopurine-9-β-D-2',3'-dideoxyribofuranoside
US5663154A (en) 2',3'-dideoxy-3'-fluoro-purine ribonucleosides
AP73A (en) Therapeautic nucleosides.
EP0306597B1 (fr) Nucléosides antiviraux
EP0479822B1 (fr) Nucleosides therapeutiques
US5175274A (en) Therapeutic nucleosides
WO1988009332A1 (fr) Nucleosides a usage therapeutique
EP0366287A1 (fr) Nucléosides thérapeutiques
CA1336821C (fr) Nucleosides pour usage therapeutique
CA1327005C (fr) Nucleosides therapeutiques
NZ224007A (en) 3'-azido-3'-deoxythymidine derivatives as antiviral agents